Dutch Pharma Stock News

Arcadis (ENXTAM:ARCAD) has kicked off a leadership transition that investors cannot ignore, nominating long serving executive Heather Polinsky as both future CEO and Chair of the Executive Board from March 2026. See our latest analysis for Arcadis. Those leadership moves come as Arcadis trades at €35.88, with weak recent momentum reflected in its roughly 39 percent year to date share price return and a one year total shareholder return of about minus 40 percent, alongside a five year total...

Earlier this month, ASM International announced that its Supervisory Board intends to reappoint CEO Hichem M’Saad for a second four-year term, while chair Pauline van der Meer Mohr plans to retire around the 2027 AGM once a suitable successor is in place. At the same time, Morgan Stanley singled out ASM International as its top European semiconductor equipment name, highlighting the company’s focus on advanced logic and foundry tools used in AI-driven chip production. We’ll now examine how...

Flow Traders (ENXTAM:FLOW) just deepened its push into digital assets by agreeing to act as strategic market maker for Dinari’s tokenized U.S. equities platform, enabling 24/7 trading with instant settlement and continuous liquidity. See our latest analysis for Flow Traders. Despite the recent Dinari deal underscoring Flow Traders’ digital asset ambitions, the share price has been more measured, with a year to date share price return of 7.35 percent and a 1 year total shareholder return of...

Koninklijke Philips (ENXTAM:PHIA) just doubled down on its 2026 outlook while rolling out two headline technologies, LumiGuide and the BlueSeal Horizon 3.0T MRI platform. This combination quietly strengthens its long term healthcare tech story. See our latest analysis for Koninklijke Philips. Those product launches and the reaffirmed 2026 outlook arrive after a choppy stretch, with a 30 day share price return of minus 7.99% and a three year total shareholder return of 94.89%. This suggests...

ABN AMRO Bank (ENXTAM:ABN) just struck a major risk transfer deal with Blackstone, shifting first loss exposure on a 2 billion euro corporate loan portfolio. This move directly affects its capital flexibility. See our latest analysis for ABN AMRO Bank. The Blackstone deal lands at a time when momentum is clearly building, with ABN AMRO’s 30 day share price return of 9.78 percent feeding into a striking 98.86 percent year to date share price gain and a 118.90 percent one year total shareholder...

ASR Nederland (ENXTAM:ASRNL) has secured regulatory approval to use its Partial Internal Model for a.s.r. Life, a technical but meaningful upgrade in how the insurer measures and manages its capital and risk. See our latest analysis for ASR Nederland. The latest Partial Internal Model approval lands on a share price that has already climbed to $58.72, with a strong year to date share price return underpinning a robust 1 year total shareholder return and impressive multi year total shareholder...

Wondering if Adyen is a quietly compelling opportunity or a value trap after its big run a few years ago? You are not alone, and this article is here to unpack what the current price is really asking you to believe. Today the stock trades around €1,333.8, with returns of -2.2% over the last week, -1.5% over the last month, and -11.3% over the past year. This tells us sentiment has cooled even as the long term payments story remains intact. Recently, the market has been digesting a mix of...

Universal Music Group has recently opened flagship UMusic Shop locations in New York and London, expanding its physical retail footprint alongside existing stores in Madrid and Tokyo to offer exclusive artist-inspired merchandise, immersive installations, and live fan experiences. By pairing these stores with collaborations like the “Music Is Universal” capsule with Awake NY and positioning them in cultural hubs such as Penn Plaza and Camden Market, UMG is using physical spaces to deepen...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...

Aegon Ltd. has announced a €400 million share repurchase program for 2026, split evenly between the first and second half of the year, alongside Board approval of a new buyback plan and an ongoing review of non-US units that could include Aegon UK and its majority stake in a Santander insurance joint venture. These moves come as Aegon works to shift its headquarters and legal seat to the US and rebrand as Transamerica Inc., underlining a clear push to concentrate governance, capital, and...

Recently, Dutch program Nieuwsuur reported that ASML had supplied parts to a Chinese firm allegedly linked to the country’s military, prompting the company to reiterate that all exports either fall outside licensing rules or have been cleared by the Dutch government. This raises fresh questions for investors about ASML’s exposure to geopolitics and export controls at a time when its technology is central to advanced chip manufacturing. Next, we’ll examine how heightened scrutiny of ASML’s...

Earlier this week, Wolters Kluwer Tax & Accounting Germany launched SteuerSparErklärung Online, a browser-based tax filing platform that uses the AI assistant “Alma” to answer natural-language tax questions, while Wolters Kluwer Health’s Ovid Synthesis was adopted by the American Board of Medical Specialties Portfolio Program as an official quality improvement workflow tool. Together, these moves highlight Wolters Kluwer’s push to embed AI and cloud delivery into everyday professional...

Earlier in December 2025, ING Groep reported that it had repurchased 1,710,214 shares under its ongoing €1.10 billion buyback, bringing total repurchases to 11,382,155 shares, while its American depositary receipts traded modestly higher alongside other European names in US markets. At the same time, ING’s confirmation of participation in the European Banking Authority’s 2025 Transparency Exercise underlines its focus on regulatory disclosure as it returns capital through a sizeable buyback...

Key Insights The considerable ownership by individual investors in Koninklijke Ahold Delhaize indicates that they...

Key Insights Significant control over Basic-Fit by individual investors implies that the general public has more power...

Havas (AMS:HAVAS) has had a great run on the share market with its stock up by a significant 6.0% over the last week...

In early December 2025, Galapagos NV reported updated Phase 2 ATALANTA-1 data showing high complete response rates and durable outcomes for its CD19 CAR T-cell candidate GLPG5101 in high-risk mantle cell lymphoma, with rapid manufacturing timelines and limited severe toxicities. On the same occasion, Galapagos confirmed plans to wind down its cell therapy activities, while remaining open to a potential sale, highlighting a contrast between promising clinical results and a retreat from...

Wolters Kluwer (ENXTAM:WKL) just rolled out SteuerSparErklärung Online in Germany, a browser based tax filing platform that uses its AI assistant Alma to simplify the entire return process for everyday users. See our latest analysis for Wolters Kluwer. Despite this kind of product innovation, Wolters Kluwer’s share price has had a tough stretch, with a steep year to date share price decline and weaker one year total shareholder return. However, the five year total shareholder return remains...

Morgan Stanley putting ASM International (ENXTAM:ASM) at the top of its European chips list, together with a planned second term for CEO Hichem M Saad, has sharpened investor focus on the stock. See our latest analysis for ASM International. The bullish call from Morgan Stanley, combined with CEO continuity, comes as ASM International’s share price has surged, including a 6.92% 1 day share price return and 30.98% 90 day share price return. Its 5 year total shareholder return of 245.10%...

Theon International (ENXTAM:THEON) has quietly delivered a strong run this year, with the stock nearly doubling over the past 12 months, prompting investors to ask whether the current valuation still looks reasonable. See our latest analysis for Theon International. With the latest share price sitting at $32.0 and a powerful year to date share price return of 142.42 percent plus a one year total shareholder return of 197.36 percent, momentum clearly looks to be building as investors reassess...

ASML Holding (ENXTAM:ASML) has quietly pushed higher this month, and that is catching investors attention. With the stock up around 9% in the past month and 41% over the past year, the key question is whether the gains still make sense relative to its earnings power. See our latest analysis for ASML Holding. That latest move comes on top of a strong backdrop, with a 30 day share price return of around 9 percent feeding into a one year total shareholder return of roughly 42 percent. This...

In recent weeks, Royal Philips reiterated its 2026 earnings guidance and unveiled two major RSNA 2025 innovations: LumiGuide, an AI-enabled, radiation-free 3D navigation solution now commercially available across Europe and the US, and BlueSeal Horizon, a helium-free 3.0T MRI platform aimed at simplifying installation and reducing lifecycle risk. Together, these advances highlight Philips’ push to pair intelligent imaging with sustainability, potentially reshaping how hospitals approach...

Prosus (ENXTAM:PRX) just paired a strong earnings beat with a big capital return story, as half year sales and net income jumped sharply, which puts the recent share price pullback into a different light. See our latest analysis for Prosus. Even after a 13.05% 1 month share price pullback and a softer 7 day move, Prosus still boasts a hefty 34.55% year to date share price return and a 77.31% three year total shareholder return, suggesting longer term momentum remains firmly intact. If Prosus...

If you are wondering whether Koninklijke Philips is a bargain or a value trap at around €22.72, this article will walk you through what the numbers actually say, without the noise. The stock has pulled back recently, down 6.2% over the last week, 7.4% over the past month, and 7.2% year to date, but it is still up 92.9% over three years despite being 37.7% lower than five years ago. These moves follow a series of developments around product safety settlements and ongoing restructuring, which...